 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Nabriva Therapeutics plc (NBRV)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-11-30 Tax Withholding | 2020-12-01 8:21 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 301 | $0.427 | 167,240 (Direct) | View |
| 2020-11-30 Tax Withholding | 2020-12-01 8:21 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 1,211 | $0.427 | 646,396 (Direct) | View |
| 2020-11-30 Tax Withholding | 2020-12-01 8:22 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 312 | $0.427 | 205,728 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 5:12 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 37 | $2.42 | 20,307 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 5:13 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 63 | $2.42 | 35,729 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 5:14 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 30 | $2.42 | 16,694 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 5:15 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 121 | $2.42 | 64,518 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 5:16 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 32 | $2.42 | 20,540 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 7:57 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 42,500 | $0 | 78,229 (Direct) | View |
| 2021-01-29 Tax Withholding | 2021-02-02 7:57 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 75 | $2.62 | 78,154 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 8:00 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 22,500 | $0 | 39,194 (Direct) | View |
| 2021-01-29 Tax Withholding | 2021-02-02 8:00 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 36 | $2.62 | 39,158 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 8:01 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 117,500 | $0 | 182,018 (Direct) | View |
| 2021-01-29 Tax Withholding | 2021-02-02 8:01 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 125 | $2.62 | 181,893 (Direct) | View |
| 2021-01-31 Tax Withholding | 2021-02-02 8:01 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 37 | $2.62 | 20,503 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 8:06 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 22,500 | $0 | 42,807 (Direct) | View |
| 2021-01-29 Tax Withholding | 2021-02-02 8:06 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 43 | $2.62 | 42,764 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 7:37 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 38 | $2.39 | 42,726 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 7:39 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 63 | $2.39 | 78,091 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 7:40 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer | 33 | $2.39 | 39,125 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 7:42 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 106 | $2.39 | 181,787 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 7:43 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Sender Gary CFO | 31 | $2.39 | 20,472 (Direct) | View |
| 2021-03-31 Option Award | 2021-04-02 6:09 pm | N/A 2031-03-30 | Nabriva Therapeutics plc | NBRV | Dolan Daniel CFO | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-03-31 Tax Withholding | 2021-04-02 6:11 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 107 | $1.66 | 181,680 (Direct) | View |
| 2021-03-31 Tax Withholding | 2021-04-02 6:12 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 37 | $1.66 | 42,689 (Direct) | View |
| 2021-03-31 Tax Withholding | 2021-04-02 6:14 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 63 | $1.66 | 78,028 (Direct) | View |
| 2021-02-06 Tax Withholding | 2021-04-08 9:46 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 870 | $2.9 | 41,819 (Direct) | View |
| 2021-02-06 Tax Withholding | 2021-04-08 9:46 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 71 | $1.79 | 41,748 (Direct) | View |
| 2021-02-06 Tax Withholding | 2021-04-08 9:46 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 74 | $1.73 | 41,674 (Direct) | View |
| 2021-02-06 Tax Withholding | 2021-04-08 9:47 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 1,104 | $2.9 | 76,924 (Direct) | View |
| 2021-02-06 Tax Withholding | 2021-04-08 9:47 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 92 | $1.79 | 76,832 (Direct) | View |
| 2021-02-06 Tax Withholding | 2021-04-08 9:47 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 92 | $1.73 | 76,740 (Direct) | View |
| 2021-02-06 Tax Withholding | 2021-04-08 9:48 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 2,695 | $2.9 | 178,985 (Direct) | View |
| 2021-02-06 Tax Withholding | 2021-04-08 9:48 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 225 | $1.79 | 178,760 (Direct) | View |
| 2021-02-06 Tax Withholding | 2021-04-08 9:48 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 225 | $1.73 | 178,535 (Direct) | View |
| 2021-04-28 Option Award | 2021-04-30 4:47 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 290,697 | $0 | 367,437 (Direct) | View |
| 2021-04-30 Tax Withholding | 2021-05-04 4:03 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 107 | $1.78 | 178,428 (Direct) | View |
| 2021-04-30 Tax Withholding | 2021-05-04 4:04 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 63 | $1.78 | 367,374 (Direct) | View |
| 2021-04-30 Tax Withholding | 2021-05-04 4:04 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 37 | $1.78 | 41,637 (Direct) | View |
| 2021-05-06 Tax Withholding | 2021-05-10 5:51 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 74 | $1.49 | 41,563 (Direct) | View |
| 2021-05-06 Tax Withholding | 2021-05-10 5:52 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 92 | $1.49 | 367,282 (Direct) | View |
| 2021-05-06 Tax Withholding | 2021-05-10 5:53 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 225 | $1.49 | 178,203 (Direct) | View |
| 2021-05-31 Tax Withholding | 2021-06-02 4:10 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 63 | $1.38 | 367,219 (Direct) | View |
| 2021-05-31 Tax Withholding | 2021-06-02 4:11 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 37 | $1.38 | 41,526 (Direct) | View |
| 2021-05-31 Tax Withholding | 2021-06-02 4:12 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 107 | $1.38 | 178,096 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:50 pm | N/A 2031-06-01 | Nabriva Therapeutics plc | NBRV | CORRIGAN MARK Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:51 pm | N/A 2031-06-01 | Nabriva Therapeutics plc | NBRV | Dalton Lisa Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2021-06-06 Tax Withholding | 2021-06-08 4:05 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary | 73 | $1.34 | 41,453 (Direct) | View |
| 2021-06-06 Tax Withholding | 2021-06-08 4:09 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 92 | $1.34 | 367,127 (Direct) | View |
| 2021-06-06 Tax Withholding | 2021-06-08 4:10 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 225 | $1.34 | 177,871 (Direct) | View |